For fiscal year 2009, Spain’s expenditure on R&D declined 0.8% to €14,582 million ($19,332 million), accounting for 1.38% of GDP. The business sector accounted for 51.9% of total R&D expenditure, a decline of 6.3% from 54.9%. Tertiary education comprised 27.8%, an increase of 3.1% from 26.7%. Public administration R&D expenditure made up 20.1%, increasing 9.5% […]
According to a recently released National Bureau of Statistics report on R&D resources, China’s R&D spending is growing quickly and is slated to reach 2% of GDP in 2010. In 2009, China’s total R&D spending was CNY 580 billion ($85 billion), or 1.7% of GDP, which represents an average annual increase of 23% since 2000, […]
In an attempt to revamp science at its universities and silence critics who claim inadequate funding for basic research, particularly at the Russian Academy of Sciences (RAS), Russia’s government has implemented several programs to encourage more university research other than RAS. The programs include a “national research university” program, which now includes 40 universities. Other […]
A Tufts Center for the Study of Drug Development report indicates that pharmaceutical companies are increasingly using personalized medicine to develop drugs. According to Christopher-Paul Milne, associate director at the center, 12%–50% of drugs in development rely on a personalized medicine approach, which often involves tests to indicate which patients are most likely to experience […]
The National Institute of Health’s (NIH) Scientific Management Review Board (SMRB) has voted 12–1 to create a new translational medicine center that would combine several programs to try to get drugs to the market faster. The center would be the base for the $500 million Clinical and Translational Science Awards (CTSAs) program. This may jeopardize […]
Though the US chemical industry rebounded in 2010 after two years of declines, it still lags in growth, said American Chemistry Council (ACC) economists. Overall US chemical production volumes are estimated to increase by 3.1% in 2010 and 3.0% in 2011, compared with declines of 4.7% and 4.5% in 2008 and 2009, respectively. Excluding pharmaceuticals, […]
Third-quarter 2010 IBO Life Science Index sales grew 7.2%, 8.5% excluding currency, to $2,944.55 million. Operating profit improved 11.5% to $636.50 million, and operating margin gained 110 basis points to 22.5% of sales. Third-quarter revenue for Beckman Coulter’s Life Sciences segment declined 5.1%, 4.1% at constant currency, to $106.1 million to account for 12% of […]
Hopkinton and Woburn, MA 12/9/10—Life science instrument provider Caliper Life Sciences has agreed to acquire Cambridge Research & Instrumentation (CRi) for $20.0 million. CRi develops and markets preclinical and tissue-based multiplexed analysis systems. The company is expected to have 2010 revenues of $12.0 million. Caliper stated that the technology should deliver a growth rate of […]
South San Francisco, CA 12/3/10; Washington, DC 12/3/10—Fluidigm has filed an S-1 registration statement with the SEC for an IPO. Fluidigm provides microfluidic instrumentation and consumables for life science research, including gene expression, genotyping and digital PCR (see page 12). The number of shares and price range has not yet been determined. In 2009, the […]
New York, NY 12/9/10—Citing three people familiar with the matter, Bloomberg reported on December 9 that Beckman Coulter is considering a sale of the company or going private and has hired Goldman Sachs Group to study the matter. Possible buyers include private equity groups, industrial conglomerates or diagnostics companies. A decision is not expected for […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
